The new frontier of cancer research is in space
Summary
Dr. Katrina Jamieson and Dr. Minil Datta discuss how microgravity accelerates tumor growth, enabling rapid cancer research on the ISS. They explain that space stress activates the ADAR1 gene, leading to the development of Rebexinib, a potential drug for various malignancies. The episode also covers how space studies reveal immune system behaviors and resilience mechanisms in astronauts, offering new insights into treating glioblastoma and autoimmune disorders.
Topics discussed
Sponsor message from Progressive Insurance
Introduction: Cancer research on the ISS
Why tumors grow faster in space and the 'dark genome'
Microgravity benefits for 3D tumor organoids
Astronaut safety and stem cell resilience
Immune system suppression in space
Rebexinib drug discovery and clinical trials
Commercial break
Glioblastoma research and future space missions
Commercial space labs and human vs AI research
Space medicine for autoimmune and neurodegenerative diseases
Concluding thoughts and credits
Listen ad-free on Castria